VolitionRX Limited (VNRX): More eavesdropping: gordoncamelio...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	481
Posts	60441
Boards Moderated	18
Alias Born	09/20/2001

XenaLives

Re: None

Wednesday, 06/03/2020 7:47:06 AM

Wednesday, June 03, 2020 7:47:06 AM

More eavesdropping:

gordoncamelion wrote on 20.05.20 11:13:27 Entry No. 1.763 (63,747,802) The results from the large lung cancer study should come in Q2 2020. Here are the topics that will come this year. Upcoming Milestones We expect the company to accomplish some of the near-term milestones below: ? Q2 Clinical performance data from individual assays and in the panel combinations across the range of cancers ? Q2 / 3 Clinical data from COVID-19 studies currently underway ? Advance large-scale colorectal and lung cancer trials in Europe, Asia and the US ? Determine the level of tumor associated nucleosomes using mass spectrometry and identify NEW biomarker targets ? Q2 Utilize Nu.Q sequencing to identify tumor of origin and specific mutations ? Q3 Utilize in conjunction with Nu.Q immunoassay approach to enhance performance ? Q4 Launch Nu. Q Vet

https://www.wallstreet-online.de/diskussion/1275261-1761-1770/bluttest-krebserkennung-valitionrx-was